Our Family Of Brands:
Our Family Of Brands:
: It proposes a robust control strategy that includes real-time release testing (RTRT) and risk-based process monitoring. Strengths
The drug substance was formulated in 20 mM Histidine, 5% Sucrose, 0.02% Polysorbate 80, pH 6.0. Note: Polysorbate 80 was selected over PS20 due to lower hydrolysis risk observed in accelerated stability studies (40°C for 1 month). A Mab A Case Study In Bioprocess Development
The team is now evaluating a continuous manufacturing (connected N-1 perfusion to capture) for Phase II to further reduce COGs by an estimated 35%. : It proposes a robust control strategy that